WHO Issues Global Alert After Cough Syrup Deaths in India, Here's What We Know

The World Health Organization (WHO) issued a global health alert after three cough syrups produced in India were found to contain a highly toxic chemical. The organisation has requested all the health authorities across the globe to remain vigilant and inform them if these drugs are found anywhere. As per the WHO Report, the syrups detected are:

• Coldrif: by Sresan Pharmaceuticals
• Respifresh TR: by Rednex Pharmaceuticals
• ReLife: by Shape Pharma

WHO warned that these drugs are likely to lead to serious and potentially life-threatening disease.

Why Did WHO Ban These 3 Cough Syrups?

India's Central Drugs Standard Control Organisation (CDSCO) confirmed that these poisonous cough syrups were ingested by young children in Madhya Pradesh's Chhindwara district. At least 22 children under the age of five have succumbed to death, the majority belonging to the Parasia area. Some others are admitted to hospitals in Nagpur, Maharashtra.

Also Read: Whooping cough: 7 Tests For Children Before It Gets Serious 

Toxic Chemical Found 500 Times Over Limit

The WHO report stated that lab analysis detected Diethylene Glycol (DEG) in the syrups, nearly 500 times the safe level. DEG is a toxic solvent that can harm kidneys and the nervous system and is lethal, particularly for children.

No Export, Authorities Say

CDSCO has made it clear that all of the adulterated syrups were not exported to any other country outside India. The US Food and Drug Administration (FDA) also assured that the medicines were not exported to the United States and illegal exports have not been reported.

States-wise Plan of Action on Cough Syrup Ban

After the deaths, a number of Indian states have taken severe measures. Here’s the breif of what went on in the country:

• Some states have totally prohibited cough syrups for kids below two years of age.
• Tamil Nadu officials have revoked the manufacturing license of Sresan Pharmaceuticals, the manufacturer of Coldrif.
• The firm has been directed to close down its operations following the discovery of 48.6% DEG in the syrup upon inspection by state drug officials.

Also Read: Baby’s Death From Whooping Cough Highlights Risks Of Skipping Vaccine In Pregnancy: Doctor’s Recommendation

Legal and Regulatory Crackdown

Sresan Pharmaceuticals owner G. Ranganathan was arrested by a Madhya Pradesh special investigation team.

The Enforcement Directorate (ED) also raided the premises of the company under the Prevention of Money Laundering Act.

Tamil Nadu government said other drug companies in the state will now undergo thorough inspections to check drug safety.

Although the contaminated syrups were not shipped out, WHO's alert is meant to stop any potential harm and facilitate rapid action in case these drugs end up in any market. Health professionals emphasise greater quality control, particularly in children's medicines.

Authorities are still trying to determine how the syrups were manufactured with such critically high amounts of poisonous chemicals. Stay tuned to Onlymyhealth to get further information on this.